CVE-2024-2224
Privilege Escalation via the GravityZone productManager UpdateServer.KitsManager API (VA-11466)
Improper Limitation of a Pathname to a Restricted Directory (‘Path Traversal’) vulnerability in the UpdateServer component of Bitdefender GravityZone allows an attacker to execute arbitrary code on vulnerable instances. This issue affects the following products that include the vulnerable component:
Bitdefender Endpoint Security for Linux version 7.0.5.200089 Bitdefender Endpoint Security for Windows version 7.9.9.380 GravityZone Control Center (On Premises) version 6.36.1
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- High
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
8.1
Privilege Escalation via the GravityZone productManager UpdateServer.KitsManager API (VA-11466)
Improper Limitation of a Pathname to a Restricted Directory (‘Path Traversal’) vulnerability in the UpdateServer component of Bitdefender GravityZone allows an attacker to execute arbitrary code on vulnerable instances. This issue affects the following products that include the vulnerable component:
Bitdefender Endpoint Security for Linux version 7.0.5.200089 Bitdefender Endpoint Security for Windows version 7.9.9.380 GravityZone Control Center (On Premises) version 6.36.1
- Record
CVE-2024-2224- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-22
- Updated
- 2026-11-02
EUVDEUVD-2024-27180
8.1
Improper Limitation of a Pathname to a Restricted Directory (‘Path Traversal’) vulnerability in the UpdateServer component of Bitdefender GravityZone allows an attacker to execute arbitrary code on vulnerable instances. This issue affects the following products that include the vulnerable component:
Bitdefender Endpoint Security for Linux version 7.0.5.200089 Bitdefender Endpoint Security for Windows version 7.9.9.380 GravityZone Control Center (On Premises) version 6.36.1
- Record
EUVD-2024-27180- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-2x49-6qmf-g5cq
8.1
Improper Limitation of a Pathname to a Restricted Directory (‘Path Traversal’) vulnerability in...
Improper Limitation of a Pathname to a Restricted Directory (‘Path Traversal’) vulnerability in the UpdateServer component of Bitdefender GravityZone allows an attacker to execute arbitrary code on vulnerable instances. This issue affects the following products that include the vulnerable component:
Bitdefender Endpoint Security for Linux version 7.0.5.200089 Bitdefender Endpoint Security for Windows version 7.9.9.380 GravityZone Control Center (On Premises) version 6.36.1
- Record
GHSA-2x49-6qmf-g5cq- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-22
- Updated
- 2026-11-02
NVD
8.1
Improper Limitation of a Pathname to a Restricted Directory (‘Path Traversal’) vulnerability in the UpdateServer component of Bitdefender GravityZone allows an attacker to execute arbitrary code on vulnerable instances. This issue affects the following products that include the vulnerable component:
Bitdefender Endpoint Security for Linux version 7.0.5.200089 Bitdefender Endpoint Security for Windows version 7.9.9.380 GravityZone Control Center (On Premises) version 6.36.1
- Record
CVE-2024-2224- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - CVSS 3.1
- 9.8 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-22
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2024-2224 is a high vulnerability (CVSS 8.1) in Bitdefender Endpoint Security For Linux, published April 9, 2024. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.73%, the 54th percentile. No source names a fixed version.